An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

CompletedOBSERVATIONAL
Enrollment

584

Participants

Timeline

Start Date

June 28, 2020

Primary Completion Date

May 18, 2022

Study Completion Date

December 2, 2022

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
OTHER

Observational

Observational

Trial Locations (24)

10027

Columbia University, New York

10065

Weill Cornell Medicine, New York

11215

NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn

11355

New York Presbyterian/Queens, Flushing

15213

University of Pittsburgh, Pittsburgh

19140

Temple University Lung Center, Philadelphia

21201

University of Maryland Baltimore, Baltimore

32608

North Florida/South Georgia Veterans Health System, Gainesville

35294

University of Alabama at Birmingham, Birmingham

44195

Cleveland Clinic, Cleveland

45220

Cincinnati VA Medical Center, Cincinnati

48109

University of Michigan, Ann Arbor

55417

Veteran's Administration Medical Center, Minneapolis

55440

HealthPartners Research Foundation, Minneapolis

55905

Mayo Clinic, Rochester

60611

Northwestern University, Chicago

70112

Louisiana State University, New Orleans

80206

National Jewish Medical & Research Center, Denver

90502

LA BioMed at Harbor-UCLA Medical Center, Los Angeles

93701

University of California, San Francisco-Fresno, Fresno

94143

University of California at San Francisco, San Francisco

99258

University of Washington School of Medicine, Spokane

84132-4701

University of Utah Health Sciences Center, Salt Lake City

05405

The University of Vermont, Burlington

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

University of Alabama at Birmingham

OTHER

lead

University of Minnesota

OTHER

NCT04717492 - An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI | Biotech Hunter | Biotech Hunter